Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study ; day:19 ; month:8 ; year:2024 ; pages:1-11
Journal of cardiovascular translational research ; (19.8.2024), 1-11
- Urheber
-
Vodnjov, Nina
Maver, Aleš
Teran, Nataša
Peterlin, Borut
Toplišek, Janez
Writzl, Karin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12265-024-10551-5
- URN
-
urn:nbn:de:101:1-2411052129020.993199464348
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vodnjov, Nina
- Maver, Aleš
- Teran, Nataša
- Peterlin, Borut
- Toplišek, Janez
- Writzl, Karin
- SpringerLink (Online service)
Ähnliche Objekte (12)
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy